Clinical Trials in Arizona - Capstone Therapeutics


Published: 2015-05-16 20:15:29


Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served medical conditions.  Previously, we were focused on the development and commercialization of two product platforms:  AZX100 and Chrysalin (TP508). Presenter- Jock Holliman

Categories: Events & Education
Sign in or Create an account to comment!